Docusign Inc. (NASDAQ:DOCU) Receives Consensus Recommendation of “Hold” from Brokerages

Docusign Inc. (NASDAQ:DOCU) has received a consensus rating of “Hold” from the twenty-one ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $64.6667.

Several analysts recently commented on the company. HSBC set a $53.00 price objective on Docusign in a report on Friday, February 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a report on Wednesday, January 21st. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research report on Tuesday, March 10th. UBS Group cut their price target on Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Finally, Cantor Fitzgerald reaffirmed an “outperform” rating on shares of Docusign in a research report on Wednesday, December 17th.

Docusign Price Performance

DOCU opened at $48.37 on Friday. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 32.68, a PEG ratio of 1.88 and a beta of 0.99. The firm has a 50 day moving average price of $47.40 and a 200-day moving average price of $61.71. Docusign has a twelve month low of $40.16 and a twelve month high of $94.67.

Docusign (NASDAQ:DOCU) last issued its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.06. The company had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the company posted $0.86 earnings per share. As a group, analysts expect that Docusign will post 1.17 earnings per share for the current year.

Docusign announced that its Board of Directors has initiated a stock repurchase plan on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 21% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its stock is undervalued.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
• Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
• Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
• Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
• Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
• Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
• Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Insider Buying and Selling at Docusign

In other news, Director Mary Agnes Wilderotter sold 3,000 shares of Docusign stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total transaction of $144,450.00. Following the transaction, the director owned 59,803 shares in the company, valued at $2,879,514.45. This trade represents a 4.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $46.84, for a total transaction of $281,040.00. Following the sale, the executive directly owned 79,233 shares of the company’s stock, valued at approximately $3,711,273.72. The trade was a 7.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 97,423 shares of company stock valued at $5,359,699 in the last quarter. Insiders own 1.01% of the company’s stock.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently modified their holdings of DOCU. Vanguard Group Inc. lifted its position in Docusign by 1.1% during the third quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock valued at $1,558,986,000 after purchasing an additional 225,525 shares in the last quarter. State Street Corp increased its position in Docusign by 0.9% in the fourth quarter. State Street Corp now owns 8,193,805 shares of the company’s stock worth $560,456,000 after buying an additional 77,008 shares in the last quarter. Capital World Investors raised its stake in shares of Docusign by 38.1% in the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after buying an additional 1,603,900 shares during the period. Geode Capital Management LLC raised its stake in shares of Docusign by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock worth $278,665,000 after buying an additional 18,873 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Docusign by 8.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,343,613 shares of the company’s stock valued at $228,703,000 after buying an additional 251,639 shares in the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.